Vaccines
![Moderna and CEPI team up for 100 Days Mission](https://pharmtales.com/wp-content/uploads/2023/10/Moderna-partners-with-CEPI-to-speed-up-vaccine-development-for-future-pandemics.jpg)
Moderna partners with CEPI to speed up vaccine development for future pandemics
Moderna is teaming up with the Coalition for Epidemic Preparedness Innovations (CEPI) to contribute to the 100 Days Mission, an ...
![Novavax partners with TV show star to promote COVID-19 vaccine choice and awareness](https://pharmtales.com/wp-content/uploads/2023/10/Novavax-partners-with-TV-show-star-to-promote-COVID-19-vaccine-choice-and-awareness.jpg)
Novavax partners with TV show star to promote COVID-19 vaccine choice and awareness
Novavax is gearing up for a robust marketing push to secure a share of the COVID-19 booster vaccine market this ...
![mRNA vaccine nobel prize 2023, mRNA vaccine discovery and development, COVID-19 vaccine nobel prize, mRNA vaccine technology and benefits, Nobel Prize for medicine 2023 winners, mRNA vaccine pioneers and history, COVID-19 pandemic and mRNA vaccine response,](https://pharmtales.com/wp-content/uploads/2023/10/mRNA-vaccine-pioneers-won-the-Nobel-Prize-for-medicine-amid-COVID-19-pandemic.jpg)
mRNA vaccine pioneers won the Nobel Prize for medicine amid COVID-19 pandemic
Two visionary scientists, Dr. Katalin Karikó and Dr. Drew Weissman, have been honored with the prestigious Nobel Prize for their ...
![CDC, flu vaccine, Awareness campaign, vaccines, Seasonal flu vaccine](https://pharmtales.com/wp-content/uploads/2023/09/CDC-launches-‘Wild-to-Mild-campaign-to-boost-flu-vaccination-rates-among-high-risk-groups.jpg)
CDC launches ‘Wild to Mild’ campaign to boost flu vaccination rates among high-risk groups
The CDC is embarking on an ambitious mission to reframe perceptions of flu vaccines as a response to declining vaccination ...
![Moderna has announced that its new COVID-19 vaccine candidate, mRNA-1283, can neutralize the Pirola variant of the coronavirus. The company is awaiting approval from regulators to start clinical trials.](https://pharmtales.com/wp-content/uploads/2023/09/Moderna-claims-new-COVID-19-vaccine-can-protect-against-Pirola-variant.jpg)
Moderna Claims New COVID-19 Vaccine Can Protect Against Pirola Variant
Moderna is vigorously advocating for the expedited approval of its updated COVID-19 vaccine in preparation for the upcoming fall vaccination ...
![Moderna, COVID-19, Pfizer, Novavax, vaccines, mRNA Vaccine](https://pharmtales.com/wp-content/uploads/2023/08/Diversifying-Strategies-as-Vaccine-Demand-Shifts_-COVID-19-Vaccine-Manufacturers-Anticipate-Fall-Inoculation-Season.jpg)
Diversifying Strategies as Vaccine Demand Shifts: COVID-19 Vaccine Manufacturers Anticipate Fall Inoculation Season
Amidst a challenging environment of declining demand for COVID-19 vaccines, producers are eagerly awaiting the upcoming fall inoculation season as ...
![The pipeline for RSV, influenza, meningitis, and pneumococcal disease vaccines raises the bar - Pharmtales - Latest Pharma News & Analysis](https://pharmtales.com/wp-content/uploads/2023/06/The-pipeline-for-RSV-influenza-meningitis-and-pneumococcal-disease-vaccines-raises-the-bar-Pharmtales-Latest-Pharma-News-Analysis.jpg)
The pipeline for RSV, influenza, meningitis, and pneumococcal disease vaccines raises the bar
Source – Sanofi On June 29, 2023, Sanofi is hosting an investor event focused on its Vaccines pipeline, featuring key ...
![FDA committee to talk about choosing the right strain for the subsequent round of COVID-19 boosts](https://pharmtales.com/wp-content/uploads/2023/06/FDA-committee-to-talk-about-choosing-the-right-strain-for-the-subsequent-round-of-COVID-19-boosts.jpg)
FDA committee to talk about choosing the right strain for the subsequent round of COVID-19 boosts
Source – FDA The FDA’s Advisory Committee on Vaccines and Related Biological Products will meet on 15 June to discuss ...